A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä
The Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update
Tekijät: Rewers M, Hyöty H, Lernmark Å, Hagopian W, She JX, Schatz D, Ziegler AG, Toppari J, Akolkar B, Krischer J
Kustantaja: CURRENT MEDICINE GROUP
Julkaisuvuosi: 2018
Journal: Current Diabetes Reports
Tietokannassa oleva lehden nimi: CURRENT DIABETES REPORTS
Lehden akronyymi: CURR DIABETES REP
Artikkelin numero: ARTN 136
Vuosikerta: 18
Numero: 12
Sivujen määrä: 14
ISSN: 1534-4827
eISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-018-1113-2
Tiivistelmä
Purpose of ReviewThe environmental triggers of islet autoimmunity leading to type 1 diabetes (T1D) need to be elucidated to inform primary prevention. The Environmental Determinants of Diabetes in the Young (TEDDY) Study follows from birth 8676 children with T1D risk HLA-DR-DQ genotypes in the USA, Finland, Germany, and Sweden. Most study participants (89%) have no first-degree relative with T1D. The primary outcomes include the appearance of one or more persistent islet autoantibodies (islet autoimmunity, IA) and clinical T1D.Recent FindingsAs of February 28, 2018, 769 children had developed IA and 310 have progressed to T1D. Secondary outcomes include celiac disease and autoimmune thyroid disease. While the follow-up continues, TEDDY has already evaluated a number of candidate environmental triggers, including infections, probiotics, micronutrient, and microbiome.SummaryTEDDY results suggest that there are multiple pathways leading to the destruction of pancreatic beta-cells. Ongoing measurements of further specific exposures, gene variants, and gene-environment interactions and detailed omics studies will provide novel information on the pathogenesis of T1D.
Purpose of ReviewThe environmental triggers of islet autoimmunity leading to type 1 diabetes (T1D) need to be elucidated to inform primary prevention. The Environmental Determinants of Diabetes in the Young (TEDDY) Study follows from birth 8676 children with T1D risk HLA-DR-DQ genotypes in the USA, Finland, Germany, and Sweden. Most study participants (89%) have no first-degree relative with T1D. The primary outcomes include the appearance of one or more persistent islet autoantibodies (islet autoimmunity, IA) and clinical T1D.Recent FindingsAs of February 28, 2018, 769 children had developed IA and 310 have progressed to T1D. Secondary outcomes include celiac disease and autoimmune thyroid disease. While the follow-up continues, TEDDY has already evaluated a number of candidate environmental triggers, including infections, probiotics, micronutrient, and microbiome.SummaryTEDDY results suggest that there are multiple pathways leading to the destruction of pancreatic beta-cells. Ongoing measurements of further specific exposures, gene variants, and gene-environment interactions and detailed omics studies will provide novel information on the pathogenesis of T1D.
Turun yliopiston Tutkimustietojärjestelmän portaali